Jump to ContentJump to Main Navigation

Methods in Next Generation Sequencing

1 Issue per year


VERSITA Emerging Science

Open Access

Open Access

Using NextGen sequencing to identify the molecular basis for genetic disease: an evolutionary perspective

1Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center

This content is open access.
(CC BY-NC-ND 4.0)

Citation Information: Methods in Next Generation Sequencing. Volume 1, Pages 1–9, ISSN (Online) 2084-7173, DOI: 10.2478/mngs-2012-0001, November 2012

Publication History:
Received:
2012-05-03
Accepted:
2012-10-23
Published Online:
2012-11-21

Abstract

In this review, I consider how genetic diseases are related to the evolution of humans and the importance of understanding the results from NextGen sequencing projects in this context. Genome wide association studies (GWAS) were predicated on the assumption that genetic disease was caused by many small effect variations found in large numbers of individuals. However, NextGen sequencing has demonstrated that many disease-causing mutations have a large effect and occur only within restricted populations, families or even individuals. The frequency with which specific types of mutations occur, their effect size and their distribution within the human population is currently an area of active research in genetics. A greater appreciation of human evolutionary history will allow us to design more informative studies to address these questions and properly interpret their results.

Keywords: High-throughput Dna sequencing; Evolution; Mutation; Genetic variation; Genetic diseases; Comparative genomics

  • Elmer K.R., Meyer A., Adaptation in the age of ecological genomics: insights from parallelism and convergence, Trends Ecol. Evol., 2011, 26, 298-306 [CrossRef] [PubMed]

  • Stapley J., Reger J., Feulner P.G., Smadja C., Galindo J., Ekblom R., Bennison C., Ball A.D., Beckerman A.P., Slate J., Adaptation genomics: the next generation, Trends Ecol Evol., 2010, 25, 705-712 [CrossRef] [PubMed]

  • Stoneking M., Krause J., Learning about human population history from ancient and modern genomes, Nat. Rev. Genet., 2011, 12, 603-614 [PubMed] [CrossRef]

  • Nelen M., Veltman J.A., Genome and exome sequencing in the clinic: unbiased genomic approaches with a high diagnostic yield, Pharmacogenomics, 2012, 13, 511- 514 [PubMed] [CrossRef]

  • Gonzaga-Jauregui C., Lupski J.R., Gibbs R.A., Human genome sequencing in health and disease, Annu. Rev. Med., 2012, 63, 35-61 [CrossRef]

  • MacArthur D.G., Balasubramanian S., Frankish A., et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science, 2012, 335, 823-828

  • Bailey-Wilson J.E., Wilson A.F. Linkage analysis in the nextgeneration sequencing era, Hum Hered. 2011, 72, 228-236

  • Lander, E.S., The New Genomics: Global views of biology, Science, 1996, 274, 536-539

  • Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., Cho J.H., Guttmacher A.E., Kong A., Kruglyak L., Mardis E., Rotimi C.N., Slatkin M., Valle D., Whittemore A.S., Boehnke M, Clark A.G., Eichler E.E., Gibson G., Haines J.L., Mackay T.F., McCarroll S.A., Visscher P.M. Finding the missing heritability of complex diseases, Nature, 2009, 461, 747-753

  • Maher B. Personal genomes: The case of the missing heritability, Nature, 2008, 456, 18-21

  • Bustamante C.D., Burchard E.G., De la Vega F.M., Genomics for the world, Nature, 2011,75,163-165

  • Chen G., Ramos E., Adeyemo A., Shriner D., Zhou J., Doumatey A.P., Huang H., Erdos M.R., Gerry N.P., Herbert A., Bentley A.R., Xu H., Charles BA., Christman M.F., Rotimi C.N., UGT1A1 is a major locus influencing bilirubin levels in African Americans, Eur. J. Hum. Genet., 2012, 20, 463-468

  • Cabral W.A., Barnes A.M., Adeyemo A., Cushing K., Chitayat D., Porter F.D., Panny S.R., Gulamali-Majid F., Tishkoff S.A., Rebbeck T.R., Gueye S.M., Bailey-Wilson J.E., Brody L.C., Rotimi C.N., Marini J.C., A founder mutation in LEPRE1 carried by 1.5% of West Africans and 0.4% of African Americans causes lethal recessive osteogenesis imperfecta, 2012, Genet Med.

  • Fu J., Festen E. A., Wijmenga C., Multi-ethnic studies in complex traits, Hum. Mol. Genet., 2011 20, R206-R213 [CrossRef]

  • Sim X., Ong R.T., Suo C., Tay W.T., Liu J., Ng D.P., Boehnke M., Chia K.S., Wong T.Y., Seielstad M., et al., Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast Asia, PLoS Genet., 2011, 7, e1001363 [CrossRef]

  • McClellan J., King M.C., Genetic heterogeneity in human disease, Cell, 2010, 141, 210-217

  • Gravel S., Henn B.M., Gutenkunst R.N., Indap A.R., Marth G.T., Clark A.G., Yu F., Gibbs R.A., 1000 Genomes Project, Bustamante C.D., Demographic history and rare allele sharing among human populations, Proc. Natl. Acad. Sci. USA, 2011, 108, 11983-11988

  • Bamshad M.J., Ng S.B., Bigham A.W., Tabor H.K., Emond M.J., Nickerson D.A., Shendure J. Exome sequencing as a tool for Mendelian disease gene discovery, Nat. Rev. Genet., 2011, 12, 745-55 [PubMed] [CrossRef]

  • Lupski J. R., Reid J. G., Gonzaga-Jauregui C., Rio Deiros D., Chen D. C., Nazareth L., Bainbridge M., Dinh H., Jing C., Wheeler D. A., McGuire A. L., Zhang F., Stankiewicz P., Halperin J. J., Yang C., Gehman C., Guo D., Irikat R. K., Tom W., Fantin N. J., Muzny D. M., Gibbs R. A., Whole-genome sequencing in a patient with Charcot- Marie-Tooth neuropathy, N. Engl. J. Med., 2010, 362, 1181-1191

  • Muers M., Human genetics: Fruits of exome sequencing for autism, Nat. Rev. Genet., 2012, 13, 377 [PubMed] [CrossRef]

  • Gibson G., Rare and common variants: twenty arguments., Nat Rev Genet. 2012, 13, 135-145 [CrossRef] [PubMed]

  • Durbin R. M., Altshuler D., Abecasis G. R., Bentley D. R., Chakravarti A., Clark A. G., Collins F. S. et al., A map of human genome variation from population-scale sequencing, Nature, 2010, 467, 1061- 1073

  • Nielsen R., Hellmann I., Hubisz M., Bustamante C., Clark A. G., Recent and ongoing selection in the human genome, Nat. Rev. Genet., 2007, 8, 857-868 [PubMed] [CrossRef]

  • Goldstein D. B., Chikhi L., Human migrations and population structure: what we know and why it matters, Ann. Rev. Genomics Hum. Genet., 2002, 3, 129-152 [CrossRef]

  • Orr H.T., Zoghbi H.Y., Trinucleotide repeat disorders, Annu. Rev. Neurosci., 2007, 30, 575-621 [PubMed] [CrossRef]

  • Shao J., Diamond M,I., Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum. Mol. Genet., 2007,2:R115-R123 [CrossRef]

  • Thompson D., Duedal S., Kirner J., McGuffog L., Last J., Reiman A., Byrd P., Taylor M., Easton D.F., Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst. 2005, 97, 813-822

  • Willems P.J., Bottlenecks in molecular testing for rare genetic diseases, Hum. Mutat., 2008, 29, 772-775 [PubMed] [CrossRef]

  • Concannon P., Gatti R.A., Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia, Hum. Mutat., 1997, 10, 100-107 [CrossRef] [PubMed]

  • Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D. A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Frydman M., Harnik R., Patanjali S. R., Simmons A., Clines G.A., Sartiel A., Gatti R.A., Chessa L., Sanal O., Lavin M. F., Jaspers N. G., Taylor A. M., Arlett C. F., Miki T., Weissman S. M., Lovett M., Collins F. S., Shiloh Y., A single ataxia telangiectasia gene with a product similar to PI-3 kinase, Science, 1995, 268, 1749-1753

  • Soltanzadeh P., Friez M.J., Dunn D., von Niederhausern A., Gurvich O.L., Swoboda K.J., Sampson J.B., Pestronk A., Connolly A.M., Florence J.M., Finkel R.S., Bönnemann C.G., Medne L., Mendell J.R., Mathews K.D., Wong B.L., Sussman M.D., Zonana J., Kovak K., Gospe S.M. Jr., Gappmaier E., Taylor L.E., Howard M.T., Weiss R.B., Flanigan K.M., Clinical and genetic characterization of manifesting carriers of DMD mutations, Neuromuscul. Disord. 2010, 20, 499-504 [CrossRef]

  • Ng S. B., Buckingham K. J., Lee C., Bigham A. W., Tabor H. K., Dent K. M., Huff C. D., Shannon P. T., Jabs E. W., Nickerson D. A., Shendure J., Bamshad M. J., Exome sequencing identifies the cause of a mendelian disorder, Nat. Genet., 2010, 42, 30-35 [CrossRef] [PubMed]

  • Miles J. H. Autism spectrum disorders--a genetics review, Genet. Med. 2011, 13, 278-294 [PubMed] [CrossRef]

  • Charlesworth D., Willis J. H., The genetics of inbreeding depression, Nat. Rev. Genet., 2009, 10, 783-796 [PubMed] [CrossRef]

  • Postma E, Martini L, Martini P., Inbred women in a small and isolated Swiss village have fewer children, J. Evol. Biol., 2010, 23, 1468-1474

  • McKusick V. A., Hostetler J. A., Egeland J. A., Genetic studies of the Amish. Background and potentialities, Bull. Johns Hopkins Hosp., 1964, 115, 203-222

  • Puffenberger E. G., Jinks R. N., Sougnez C., Cibulskis K., Willert R. A., Achilly N. P., Cassidy R. P., Fiorentini C. J., Heiken K. F., Lawrence J. J., Mahoney M. H., Miller C. J., Nair D. T., Politi K. A., Worcester K. N., Setton R. A., Dipiazza R., Sherman E. A., Eastman J. T., Francklyn C., Robey-Bond S., Rider N. L., Gabriel S., Morton D. H., Strauss K. A., Genetic mapping and exome sequencing identify variants associated with five novel diseases, PLoS One, 2012, 7, e28936

  • Young Center for Anabaptist and Pietist Studies, Elizabethtown College. “Amish Population Trends 1991- 2010, 20-Year Highlights.” http://www2.etown.edu/ amishstudies/Population_Trends_1991_2010.asp

  • Miller K., Yost B., Flaherty S., Hillemeier M. M., Chase G. A., Weisman C. S., Dyer A. M., Health status, health conditions, and health behaviors among Amish women. Results from the Central Pennsylvania Women’s Health Study (CePAWHS), Womens Health Issues, 2007, 17, 162-171 [CrossRef]

  • Hamilton, B. E., Martin, J. A., Ventura, S. J. Births: Preliminary Data for 2007, National Vital Statistics Reports 57:12, March 18, 2009

  • Adams C. E., Leverland M. B., The effects of religious beliefs on the health care practices of the Amish, Nurse Pract. 1986, 11, 58, 63, 67 [PubMed]

  • Mitchell B. D., Hsueh W. C., King T. M., Pollin T. I., Sorkin J., Agarwala R., Schäffer A. A., Shuldiner A. R., Heritability of life span in the Old Order Amish, Am. J. Med. Genet., 2001, 102, 346-352 [PubMed] [CrossRef]

  • Berg N. Why the Amish Population Is Exploding, The Atlantic Cities, Aug 01, 2012

  • Golgowski, N., Amish population booming in the U.S. with a new settlement founded nearly once a month, Daily Mail, July 28, 2012

  • Crnokrak P., Barrett S. C. Perspective: purging the genetic load: a review of the experimental evidence. Evolution, 2002, 56, 2347-2358 [PubMed]

  • Glémin S. How are deleterious mutations purged? Drift versus nonrandom mating, Evolution, 2003, 57, 2678-2687 [PubMed]

  • Reed F. A., Aquadro, C. F. Mutation, selection and the future of human evolution, Trends Genet., 2006, 22, 479-484 [CrossRef] [PubMed]

  • Kambere M.B., Lane R.P. Co-regulation of a large and rapidly evolving repertoire of odorant receptor genes, BMC Neurosci. 2007, 8 Suppl 3, S2 [CrossRef]

  • Gilad Y., Man O., Pääbo S., Lancet D., Human specific loss of olfactory receptor genes, Proc Natl Acad Sci U S A. 2003,100, 3324–3327 [CrossRef]

  • Niimura Y., Evolutionary dynamics of olfactory receptor genes in chordates: interaction between environments and genomic contents, Hum. Genomics, 2009, 4, 107-118 [CrossRef] [PubMed]

  • Olson M.V. When less is more: gene loss as an engine of evolutionary change, Am. J. Hum. Genet. 1999, 64, 18-23 [CrossRef]

  • Ferrer-Admetlla A., Sikora M., Laayouni H., Esteve A., Roubinet F., Blancher A., Calafell F., Bertranpetit J., Casals F., A natural history of FUT2 polymorphism in humans, Mol. Biol. Evol., 2009, 26, 1993-2003 [CrossRef]

  • Smyth D.J., Cooper J.D., Howson J.M., Clarke P., Downes K., Mistry T., Stevens H., Walker N.M., Todd J.A., FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection, Diabetes, 2011, 60, 3081-3084

  • Zimmerman P.A., Buckler-White A., Alkhatib G., Spalding T., Kubofcik J., Combadiere C., Weissman D., Cohen O., Rubbert A., Lam G, Vaccarezza M., Kennedy P.E, Kumaraswami V., Giorgi J.V., Detels R., Hunter J., Chopek M., Berger E.A., Fauci A.S., Nutman T.B., Murphy P.M. (1997) Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk, Mol Med., 1997, 3, 23-36

  • Novembre J., Galvani A. P., Slatkin M., The geographic spread of the CCR5 Delta32 HIV-resistance allele. PLoS Biol., 2005, 3, e339

  • Stephens J.C., Reich D.E., Goldstein D.B., Shin H.D., Smith M.W., Carrington M., Winkler C., Huttley G.A., Allikmets R., Schriml L., Gerrard B., Malasky M., Ramos M.D., Morlot S., Tzetis M., Oddoux C., di Giovine F.S., Nasioulas G., Chandler D., Aseev M., Hanson M., Kalaydjieva L., Glavac D., Gasparini P., Kanavakis E., Claustres M., Kambouris M., Ostrer H., Duff G., Baranov V., Sibul H., Metspalu A., Goldman D., Martin N., Duffy D., Schmidtke J., Estivill X., O’Brien S.J., Dean M., Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes, Am. J. Hum. Genet. 1998, 62,1507-1515 [CrossRef]

  • Libert F., Cochaux P., Beckman G., Samson M., Aksenova M., Cao A., Czeizel A., et al, The Dccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in northeastern Europe, Hum. Mol. Genet., 1998, 7, 399–406

  • Sabeti P. C., Walsh E., Schaffner S. F., Varilly P., Fry B., Hutcheson H. B., Cullen M., Mikkelsen T. S., Roy J., Patterson N., Cooper R., Reich D., Altshuler D., O’Brien S., Lander E. S., The case for selection at CCR5-Delta32, PLoS Biol., 2005, 3, e378 [CrossRef]

  • Aidoo M., Terlouw D.J., Kolczak M.S., McElroy P.D., ter Kuile F.O., Kariuki S., Nahlen B.L., Lal A.A., Udhayakumar V., Protective effects of the sickle cell gene against malaria morbidity and mortality, Lancet, 2002, 359, 1311-1312

  • Pattanapanyasat K., Yongvanitchit K., Tongtawe P., Tachavanich K., Wanachiwanawin W., Fucharoen S., Walsh D.S., Impairment of Plasmodium falciparum growth in thalassemic red blood cells: further evidence by using biotin labeling and flow cytometry, Blood, 1999, 93, 3116-3119

  • Raber J., Huang Y., Ashford J. W., ApoE genotype accounts for the vast majority of AD risk and AD pathology, Neurobiol. Aging, 2004, 25, 641-650 [PubMed] [CrossRef]

  • Hanlon C.S., Rubinsztein D.C., Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans, Atherosclerosis 1995, 112, 85–90

  • Caselli R.J., Age-related memory decline and apolipoprotein E e4, Discov. Med., 2009, 8, 47-50

  • Caselli R.J., Dueck A.C., Osborne D., Sabbagh M.N., Connor D.J., Ahern G.L., Baxter L.C., Rapcsak S.Z., Shi J., Woodruff B.K., Locke D.E., Snyder C.H., Alexander G.E., Rademakers R, Reiman E.M., Longitudinal modeling of agerelated memory decline and the APOE epsilon4 effect. N. Engl. J. Med., 2009, 361, 255-263

  • Williams G.C., Pleiotropy, natural selection, and the evolution of senescence, Evolution, 1957, 11, 398-411 [CrossRef]

  • Hamilton W. D., The moulding of senescence by natural selection, J. Theoret. Biol., 1966, 12, 12-45.

  • Blurton Jones N.G., Hawkes K., O’Connell J.F., Antiquity of postreproductive life: are there modern impacts on huntergatherer postreproductive life spans?, Am J Hum Biol., 2002, 14, 184-205 [CrossRef] [PubMed]

  • Nyholt D. R., Yu C-E., VIsscher P. M., On Jim Watson’s APOE status: genetic information is hard to hide. European J. Human Genet., 2009, 17, 147-150.

  • Burger J., Kirchner M., Bramanti B., Haak, W., Thomas, M.G., Absence of the lactase-persistence-associated allele in early Neolithic Europeans, Proc. Natl. Acad. Sci. USA, 2007, 104, 3736-3741 [CrossRef]

  • Tishkoff S. A., Reed F. A., Ranciaro A., Voight B. F., Babbitt C. C., Silverman J. S., Powell K., Mortensen H. M., Hirbo J. B., Osman M., Ibrahim M., Omar S. A., Lema G., Nyambo T. B., Ghori J., Bumpstead S., Pritchard J. K., Wray G. A., Deloukas P., Convergent adaptation of human lactase persistence in Africa and Europe, Nature Genet. 2007, 39, 31-40 [CrossRef]

  • Parra E.J., Human pigmentation variation: evolution, genetic basis, and implications for public health, Am. J. Phys. Anthropol. 2007, Suppl 45, 85-105

  • Harris S.S., Vitamin D and African Americans, J. Nutr., 2006, 136, 1126-1129

  • Jablonski, N.G., The evolution of human skin colouration and its relevance to health in the modern world, J. R. Coll. Physicians Edinb. 2012, 42, 58-63

  • Lander E. S., Linton L. M., Birren B., et al, International Human Genome Sequencing Consortium, Initial sequencing and analysis of the human genome. Nature, 2001, 409, 860-921

  • Venter, J. C., Adams, M. D., Myers, E. W., et al, The sequence of the human genome, Science, 2001, 291, 1304-1351

  • 1000 Genomes Project Consortium, A map of human genome variation from population-scale sequencing, Nature, 2010, 467, 1061-1073

  • Zhang X., Goodsell J., Norgren R. B. Jr. Limitations of the rhesus macaque draft genome assembly and annotation, BMC Genomics, 2012, 13, 206.[CrossRef] [PubMed]

Comments (0)

Please log in or register to comment.